Stephen G. Walsh

Array ( [id] => 3419801 [patent_doc_number] => 05478804 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-26 [patent_title] => 'Treatment of tumorigenic pathophysiological conditions with FGF-cytoxic conjugates' [patent_app_type] => 1 [patent_app_number] => 8/250097 [patent_app_country] => US [patent_app_date] => 1994-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8555 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/478/05478804.pdf [firstpage_image] =>[orig_patent_app_number] => 250097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3645252 [patent_doc_number] => 05637480 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'DNA molecules encoding bone morphogenetic protein-10' [patent_app_type] => 1 [patent_app_number] => 8/247908 [patent_app_country] => US [patent_app_date] => 1994-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11821 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637480.pdf [firstpage_image] =>[orig_patent_app_number] => 247908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3647066 [patent_doc_number] => 05639638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'DNA molecules encoding bone morpogenetic protein-11' [patent_app_type] => 1 [patent_app_number] => 8/247907 [patent_app_country] => US [patent_app_date] => 1994-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13937 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639638.pdf [firstpage_image] =>[orig_patent_app_number] => 247907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729307 [patent_doc_number] => 05635374 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Bone calcification factor and recombinant production of the factor nucleic acid encoding' [patent_app_type] => 1 [patent_app_number] => 8/237243 [patent_app_country] => US [patent_app_date] => 1994-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 11338 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635374.pdf [firstpage_image] =>[orig_patent_app_number] => 237243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3604457 [patent_doc_number] => 05578703 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Substantially pure receptor like TFG-.beta.1 binding molecules' [patent_app_type] => 1 [patent_app_number] => 8/167939 [patent_app_country] => US [patent_app_date] => 1994-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5456 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578703.pdf [firstpage_image] =>[orig_patent_app_number] => 167939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3602346 [patent_doc_number] => 05578569 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Method of increasing bone growth' [patent_app_type] => 1 [patent_app_number] => 8/229009 [patent_app_country] => US [patent_app_date] => 1994-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7738 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578569.pdf [firstpage_image] =>[orig_patent_app_number] => 229009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690896 [patent_doc_number] => 05691461 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Oligonucleotides inhibiting candida germ tube formation' [patent_app_type] => 1 [patent_app_number] => 8/229145 [patent_app_country] => US [patent_app_date] => 1994-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5282 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691461.pdf [firstpage_image] =>[orig_patent_app_number] => 229145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686030 [patent_doc_number] => 05643757 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'High yield production of human apolipoprotein A1 in E. coli.' [patent_app_type] => 1 [patent_app_number] => 8/215749 [patent_app_country] => US [patent_app_date] => 1994-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4445 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643757.pdf [firstpage_image] =>[orig_patent_app_number] => 215749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3547350 [patent_doc_number] => 05545619 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Modified complement system regulators' [patent_app_type] => 1 [patent_app_number] => 8/210266 [patent_app_country] => US [patent_app_date] => 1994-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 10088 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545619.pdf [firstpage_image] =>[orig_patent_app_number] => 210266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3604535 [patent_doc_number] => 05578708 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Bone-associated transcription control factor-like protein' [patent_app_type] => 1 [patent_app_number] => 8/208108 [patent_app_country] => US [patent_app_date] => 1994-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4884 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578708.pdf [firstpage_image] =>[orig_patent_app_number] => 208108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586769 [patent_doc_number] => 05552381 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Recombinantly produced human membrane cofactor protein (MCP) pharmaceutical composition, and method of inhibiting complement activity' [patent_app_type] => 1 [patent_app_number] => 8/203867 [patent_app_country] => US [patent_app_date] => 1994-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 7023 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552381.pdf [firstpage_image] =>[orig_patent_app_number] => 203867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3573364 [patent_doc_number] => 05539083 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'Peptide nucleic acid combinatorial libraries and improved methods of synthesis' [patent_app_type] => 1 [patent_app_number] => 8/200742 [patent_app_country] => US [patent_app_date] => 1994-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21614 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/539/05539083.pdf [firstpage_image] =>[orig_patent_app_number] => 200742 [rel_patent_id] =>[rel_patent_doc_number] =>)